We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

DQ King & Spalding In Vaccine Patent Row, Ex-Client Says

Law360, New York (January 11, 2018, 5:56 PM EST) -- A German pharmaceutical company asked a New York state court Wednesday to bar King & Spalding LLP from representing two animal vaccine manufacturers in international arbitration stemming from a license agreement relating to vaccine transport technology, saying the firm was previously its own "trusted counsel."

Boehringer Ingelheim GmbH and two companies it owns, Merial Inc. and that company's French subsidiary, Merial SAS, argue that the Biglaw firm should be disqualified from representing the U.S.-based Phibro Animal Health Corp. and its Israeli subsidiary, Abic Biological Laboratories Ltd.,...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.